Blood lactate monitoring in critically ill patients: A systematic health technology assessment

被引:319
作者
Jansen, Tim C. [1 ]
van Bommel, Jasper [1 ]
Bakker, Jan [1 ]
机构
[1] Erasmus MC Univ, Med Ctr, Dept Intens Care, Rotterdam, Netherlands
关键词
health technology assessment; lactate; hyperlactatemia; ICU; cost-effectiveness; efficacy; systematic review; INTENSIVE-CARE-UNIT; K+-ATPASE ACTIVITY; GOAL-DIRECTED THERAPY; POINT-OF-CARE; VIRUS-INFECTED PATIENTS; SKELETAL-MUSCLE NA+; ACID-BASE STATUS; STRONG ION GAP; LACTIC-ACIDOSIS; OXYGEN DELIVERY;
D O I
10.1097/CCM.0b013e3181a98899
中图分类号
R4 [临床医学];
学科分类号
100218 [急诊医学];
摘要
Objective: To decide whether the use of blood lactate monitoring in critical care. practice is appropriate. We performed a systematic health technology assessment as blood lactate monitoring has been implemented widely but its clinical value in critically ill patients has never been evaluated properly. Data Source: PubMed, other databases, and citation review. Study Selection: We searched for lactate combined with critically ill patients as the target patient population. Two reviewers independently selected studies based on relevance for the following questions: Does lactate measurement: 1) perform well in a laboratory setting? 2) provide information in a number of clinical situations? 3) relate to metabolic acidosis? 4) increase workers' confidence? 5) alter therapeutic decisions? 6) result in benefit to patients? 7) result in similar benefits in your own setting? 8) result in benefits which are worth the extra costs? Data Extraction and Synthesis: We concluded that blood lactate measurement in critically ill patients: 1) is accurate in terms of measurement technique but adequate understanding of the (an)aerobic etiology is required for its correct interpretation; 2) provides not only diagnostic but also important prognostic information; 3) should be measured directly instead of estimated from other acid-base variables; 4) has an unknown effect on healthcare workers' confidence; 5) can alter therapeutic decisions; 6) could potentially improve patient outcome when combined with a treatment algorithm to optimize oxygen delivery, but this has only been shown indirectly; 7) is likely to have similar benefits in critical care settings worldwide; and 8) has an unknown cost-effectiveness. Conclusions: The use of blood lactate monitoring has a place in risk-stratification in critically ill patients, but it is unknown whether the routine use of lactate as a resuscitation end point improves outcome. This warrants randomized controlled studies on the efficacy of lactate-directed therapy. (Crit Care Med 2009; 37:2827-2839)
引用
收藏
页码:2827 / 2839
页数:13
相关论文
共 157 条
[1]
LACTATE CLEARANCE AND SURVIVAL FOLLOWING INJURY [J].
ABRAMSON, D ;
SCALEA, TM ;
HITCHCOCK, R ;
TROOSKIN, SZ ;
HENRY, SM ;
GREENSPAN, J .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1993, 35 (04) :584-589
[2]
The anion gap does not accurately screen for lactic acidosis in emergency department patients [J].
Adams, BD ;
Bonzani, TA ;
Hunter, CJ .
EMERGENCY MEDICINE JOURNAL, 2006, 23 (03) :179-182
[3]
RELATIONSHIP BETWEEN BLOOD LACTATE CONCENTRATIONS AND IONIZED CALCIUM, GLUCOSE, AND ACID-BASE STATUS IN CRITICALLY ILL AND NONCRITICALLY ILL PATIENTS [J].
ADUEN, J ;
BERNSTEIN, WK ;
MILLER, JA ;
KERZNER, R ;
BHATIANI, A ;
DAVISON, L ;
CHERNOW, B .
CRITICAL CARE MEDICINE, 1995, 23 (02) :246-252
[4]
THE USE AND CLINICAL IMPORTANCE OF A SUBSTRATE-SPECIFIC ELECTRODE FOR RAPID-DETERMINATION OF BLOOD LACTATE CONCENTRATIONS [J].
ADUEN, J ;
BERNSTEIN, WK ;
KHASTGIR, T ;
MILLER, JA ;
KERZNER, R ;
BHATIANI, A ;
LUSTGARTEN, J ;
BASSIN, AS ;
DAVISON, L ;
CHERNOW, B .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (21) :1678-1685
[5]
A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock [J].
Alía, I ;
Esteban, A ;
Gordo, F ;
Lorente, JA ;
Diaz, C ;
Rodriguez, JA ;
Frutos, F .
CHEST, 1999, 115 (02) :453-461
[6]
PROLONGATION OF THE HALF-LIFE OF LACTATE AFTER MAXIMAL EXERCISE IN PATIENTS WITH HEPATIC-DYSFUNCTION [J].
ALMENOFF, PL ;
LEAVY, J ;
WEIL, MH ;
GOLDBERG, NB ;
VEGA, D ;
RACKOW, EC .
CRITICAL CARE MEDICINE, 1989, 17 (09) :870-873
[7]
Preanalytical handling of samples for measurement of plasma lactate in HIV patients [J].
Andersen, O ;
Haugaard, SB ;
Jorgensen, LT ;
Sorensen, S ;
Nielsen, JO ;
Madsbad, S ;
Iversen, J .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2003, 63 (06) :449-454
[8]
Hemodynamic monitoring in shock and implications for management International Consensus Conference, Paris, France, 27-28 April 2006 [J].
Antonelli, Massimo ;
Levy, Mitchell ;
Andrews, Peter J. D. ;
Chastre, Jean ;
Hudson, Leonard D. ;
Manthous, Constantine ;
Meduri, G. Umberto ;
Moreno, Rui P. ;
Putensen, Christian ;
Stewart, Thomas ;
Torres, Antoni .
INTENSIVE CARE MEDICINE, 2007, 33 (04) :575-590
[9]
RELATIONSHIP OF OXYGEN DELIVERY AND MIXED VENOUS OXYGENATION TO LACTIC-ACIDOSIS IN PATIENTS WITH SEPSIS AND ACUTE MYOCARDIAL-INFARCTION [J].
ASTIZ, ME ;
RACKOW, EC ;
KAUFMAN, B ;
FALK, JL ;
WEIL, MH .
CRITICAL CARE MEDICINE, 1988, 16 (07) :655-658
[10]
ASTLES R, 1994, CLIN CHEM, V40, P1327